Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Goiter

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.

Nuklearmedizin. Nuclear medicine·2013

Same author

Calcitonin screening in patients with thyroid nodules. Diagnostic value.

Nuklearmedizin. Nuclear medicine·2012

Same author

[Thyroid disorders].

Versicherungsmedizin·2012

Same author

One should not just read what one believes: the nearly irresolvable issue of producing truly objective, evidence-based guidelines for the management of differentiated thyroid cancer.

European journal of nuclear medicine and molecular imaging·2011

Same author

Recombinant human TSH versus hypothyroidism. Cost-minimization-analysis in the follow-up care of differentiated thyroid carcinoma.

Nuklearmedizin. Nuclear medicine·2010

Same author

Risk stratification of patients with locally aggressive differentiated thyroid cancer. Results of the MSDS trial.

Nuklearmedizin. Nuclear medicine·2010

Same journal

[What do company health insurance plans provide?]

Versicherungsmedizin·2017

Same journal

[Assessment of prescriptive therapies and remedies - Experience and results].

Versicherungsmedizin·2017

Same journal

[The importance of biosimilars medicines for private and statutory health insurance].

Versicherungsmedizin·2017

Same journal

[Can we transfer the mechanisms of the generics market to biosimilars?]

Versicherungsmedizin·2017

Same journal

[Not Available].

Versicherungsmedizin·2016

Same journal

[Not Available].

Versicherungsmedizin·2016

See all related articles

Search research articles

Related Experiment Video

Updated: May 23, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

[Thyroid disorders].

M Schmidt¹, H Schicha

¹Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Köln.

Versicherungsmedizin

|April 11, 2012

Summary

This summary is machine-generated.

Thyroid disorders are common in Germany, with treatments ranging from medication to radioactive iodine therapy. Differentiated thyroid cancers are largely curable, while advanced metastatic disease presents limited options.

More Related Videos

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

Related Experiment Videos

Last Updated: May 23, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

Area of Science:

Endocrinology and Oncology
Nuclear Medicine

Context:

Thyroid disorders are prevalent in Germany, with established diagnostic and therapeutic approaches.
Adequate iodine supply has been achieved, influencing the management of thyroid conditions.

Purpose:

To provide an overview of the current landscape of thyroid disorders and their management in Germany.
To highlight treatment strategies for hyperthyroidism, hypothyroidism, and thyroid cancer.

Summary:

Common thyroid conditions include autonomous adenomas, Graves' disease, and Hashimoto's thyroiditis, managed with medication, radioactive iodine, or surgery.
Papillary and follicular thyroid carcinomas are frequently diagnosed and highly curable with surgery and radioiodine therapy.
Advanced, dedifferentiated thyroid cancer with metastases poses treatment challenges, with tyrosinase inhibitors as a novel therapeutic avenue.

Impact:

Informs clinical practice regarding the optimal management of diverse thyroid pathologies.
Highlights the efficacy of established treatments and the need for innovative therapies for advanced thyroid cancer.
Contributes to understanding the long-term outcomes and challenges in thyroid disease management.